awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35951606-00689498-6A16-40E1-BB14-0231C6557121
Q35951606-00689498-6A16-40E1-BB14-0231C6557121
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35951606-00689498-6A16-40E1-BB14-0231C6557121
Self-administered, subcutaneous alemtuzumab to treat residual disease in patients with chronic lymphocytic leukemia
P2860
Q35951606-00689498-6A16-40E1-BB14-0231C6557121
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35951606-00689498-6A16-40E1-BB14-0231C6557121
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
814a17e0c6c2af2d73b5ffb2e8ca9cd484841f3f
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.